Type II Variations for Yescarta and Tecartus Listed in July’s CHMP Agenda
Here is a brief preview of this blast: On Monday, July 18, the CHMP agenda for July was released. Of note, Yescarta and Tecartus (Gilead / Kite's autologous CD19 CAR-Ts) have been listed as 'For adoption' under the ‘Type II Variations – Opinion or Requests for Supplementary Information’ section for 2L LBCL and r/r adult B-ALL, respectively.